Terms: = Germ cell tumor AND SDHAF2, ENSG00000167985, C11orf79, FLJ20487, 54949 AND Treatment
10 results:
1. The emerging clinical relevance of genomic profiling in neuroendocrine tumours.
Burak GI; Ozge S; Cem M; Gulgun B; Zeynep DY; Atil B
BMC Cancer; 2021 Mar; 21(1):234. PubMed ID: 33676450
[TBL] [Abstract] [Full Text] [Related]
2. The Changing Paradigm of Head and Neck Paragangliomas: What Every Otolaryngologist Needs to Know.
Cass ND; Schopper MA; Lubin JA; Fishbein L; Gubbels SP
Ann Otol Rhinol Laryngol; 2020 Nov; 129(11):1135-1143. PubMed ID: 32486832
[TBL] [Abstract] [Full Text] [Related]
3. Malignant Intrarenal/Renal Pelvis Paraganglioma with Co-Occurring SDHB and ATRX Mutations.
Irwin T; Konnick EQ; Tretiakova MS
Endocr Pathol; 2019 Dec; 30(4):270-275. PubMed ID: 31705439
[TBL] [Abstract] [Full Text] [Related]
4. Pheochromocytoma, paragangliomas, and pituitary adenoma: An unusual association in a patient with an SDHD mutation. Case report.
Lemelin A; Lapoirie M; Abeillon J; Lasolle H; Giraud S; Philouze P; Ceruse P; Raverot G; Vighetto A; Borson-Chazot F
Medicine (Baltimore); 2019 Jul; 98(30):e16594. PubMed ID: 31348302
[TBL] [Abstract] [Full Text] [Related]
5. PHEOCHROMOCYTOMA: A GENETIC AND DIAGNOSTIC UPDATE.
Mercado-Asis LB; Wolf KI; Jochmanova I; Taïeb D
Endocr Pract; 2018 Jan; 24(1):78-90. PubMed ID: 29144820
[TBL] [Abstract] [Full Text] [Related]
6. PRECISION MEDICINE: AN UPDATE ON GENOTYPE/BIOCHEMICAL PHENOTYPE RELATIONSHIPS IN PHEOCHROMOCYTOMA/PARAGANGLIOMA PATIENTS.
Gupta G; Pacak K;
Endocr Pract; 2017 Jun; 23(6):690-704. PubMed ID: 28332883
[TBL] [Abstract] [Full Text] [Related]
7. Connecting molecular pathways to hereditary cancer risk syndromes.
Testa JR; Malkin D; Schiffman JD
Am Soc Clin Oncol Educ Book; 2013; ():81-90. PubMed ID: 23714463
[TBL] [Abstract] [Full Text] [Related]
8. Genetics of pheochromocytoma and paraganglioma syndromes: new advances and future treatment options.
Vicha A; Musil Z; Pacak K
Curr Opin Endocrinol Diabetes Obes; 2013 Jun; 20(3):186-91. PubMed ID: 23481210
[TBL] [Abstract] [Full Text] [Related]
9. Head and neck paragangliomas: clinical and molecular genetic classification.
Offergeld C; Brase C; Yaremchuk S; Mader I; Rischke HC; Gläsker S; Schmid KW; Wiech T; Preuss SF; Suárez C; Kopeć T; Patocs A; Wohllk N; Malekpour M; Boedeker CC; Neumann HP
Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):19-28. PubMed ID: 22584701
[TBL] [Abstract] [Full Text] [Related]
10. Peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE in individuals with neck or mediastinal paraganglioma (PGL).
Zovato S; Kumanova A; Demattè S; Sansovini M; Bodei L; Di Sarra D; Casagranda E; Severi S; Ambrosetti A; Schiavi F; Opocher G; Paganelli G
Horm Metab Res; 2012 May; 44(5):411-4. PubMed ID: 22566197
[TBL] [Abstract] [Full Text] [Related]
